KALV
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. (KALV) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 75.9 (overbought), with 3/3 trend checks passing.
KALV with MA50 and MA200
Key levels & signals
KalVista Pharmaceuticals, Inc. (KALV) is still trading in a constructive trend overall. The latest available price is $27.00, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 11.1% and above the 200-day moving average by 59.0%.
KALV currently has an RSI reading of 75.9, which points to very strong short-term momentum but also a fairly extended setup. Stocks can stay strong for longer than expected, but this kind of reading often tells beginners not to confuse strength with low-risk entry timing.
For traders reviewing KALV next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.
KALV shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about KALV
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.